All AbMole products are for research use only, cannot be used for human consumption.
Glycyrrhizic acid is a triterpenoid saponinl, acting as a direct HMGB1 antagonist, with anti-tumor, anti-diabetic activities. Glycyrrhizic acid may have potential as a therapeutic agent in cerebral ischemia by preventing oxidative stress. Glycyrrhizic acid would be a promising carrier for the oral delivery of PTX.
Molecular Weight | 822.94 |
Formula | C42H62O16 |
CAS Number | 1405-86-3 |
Solubility (25°C) | DMSO 90 mg/mL |
Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
Related HMGB1 Products |
---|
HBP08
HBP08 is a high mobility group protein B1 (HMGB1) modulator that can be used in studies related to inflammation. |
18-mer-HP
18-mer-HP is a high mobility group protein B1 (HMGB1) modulator that can be used in studies related to acute liver failure. |
AFX-2101
AFX-2101 is a high mobility group protein B1 (HMGB1) modulator for studies related to CNS trauma. |
SB1703
SB1703 is a high mobility group protein B1 (HMGB1) modulator for melanoma-related studies. |
SB17170
SB17170 is an HMGB1 modulator that can be used in studies related to solid tumors. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.